Notifiable share interest in Theravance, Inc.

RNS Number : 7103L

GlaxoSmithKline PLC

03 August 2011

 



Notifiable Share Interest in Theravance, Inc.

GlaxoSmithKline plc ("GSK") announces that on 2 August 2011 GSK purchased 102,466 shares of Common Stock of Theravance, Inc. ("Theravance") at a price of $19.71 per share, for a total investment of $2,019,604,86. These shares were purchased from Theravance pursuant to GSK's right to acquire, on a quarterly basis, sufficient shares of common stock to maintain its ownership percentage in Theravance, taking into account the preceding quarter's net option exercise and equity vesting activity.

GSK's interest in Theravance now comprises 15,667,542 shares of Common Stock, which together represents approximately 19.01% of Theravance's outstanding capital stock. The calculation is based on a total of 82,417,371 shares of Common Stock and Class A Common Stock outstanding in Theravance after this transaction.  This purchase is disclosable and will be reported under the rules of the Securities and Exchange Commission.

Victoria Whyte

Company Secretary

3 August 2011

 

END

 

 

ACQLLFLDTSIVIIL